Novo Nordisk A/S Common Stock (NVO)

Depreciation & Amortization

kr 27.16B

TTM · Period ending: · DKK

NVO logo

NVO Depreciation & Amortization

Latest reportedkr 27.16B DKK
NVO TTM Depreciation & Amortization · DKK (kr 0.00 → kr 27.16B)
High-resolution chart · PNG

NVO depreciation & amortization history

Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.

Novo Nordisk A/S Common Stock Depreciation & Amortization — Trailing twelve months (TTM) (DKK)
Period endingDepreciation & Amortization (DKK)
27,159,000,000
21,688,000,000
21,982,000,000
21,618,000,000
16,011,000,000
20,023,000,000
19,107,000,000
16,901,000,000
17,276,000,000
10,608,000,000
9,413,000,000
7,647,000,000
7,163,000,000
6,622,000,000
6,553,000,000
7,409,000,000
6,717,000,000
6,298,000,000
6,025,000,000
5,322,000,000
6,103,000,000
6,044,000,000
5,753,000,000
5,772,000,000
5,737,000,000
5,689,000,000
5,661,000,000
5,905,000,000
4,593,000,000
4,251,000,000
3,925,000,000
3,188,000,000
3,111,000,000
3,206,000,000
3,182,000,000
3,393,000,000
3,423,000,000
3,277,000,000
3,193,000,000
3,092,000,000
2,989,000,000
2,920,000,000
2,959,000,000
2,713,000,000
3,263,000,000
3,282,000,000
3,276,000,000
3,152,000,000
2,612,000,000
2,621,000,000
2,655,000,000
2,645,000,000
2,002,000,000
1,326,000,000
635,000,000
0
615,000,000
1,440,000,000
2,045,000,000
2,729,000,000
2,721,000,000
2,491,000,000
2,467,000,000
1,783,000,000
1,833,000,000
1,771,000,000
1,797,000,000
1,797,000,000
1,140,000,000
607,000,000
0
0
0
0
0
0
0
0
461,711,000
461,711,000
461,711,000
461,711,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.